Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Farzaneh Barkhordari, Nooshin Sohrabi, Fatemeh Davami, Fereidoun Mahboudi & Yeganeh Talebkhan Garoosi. (2019) Cloning, expression and characterization of a HER2-alpha luffin fusion protein in Escherichia coli. Preparative Biochemistry & Biotechnology 49:8, pages 759-766.
Read now
Read now
George Manoukian & Fred Hagemeister. (2009) Denileukin diftitox: a novel immunotoxin. Expert Opinion on Biological Therapy 9:11, pages 1445-1451.
Read now
Read now
Minghui Li, Kai Sun, Lisbeth A Welniak & William J Murphy. (2008) Immunomodulation and pharmacological strategies in the treatment of graft-versus-host disease. Expert Opinion on Pharmacotherapy 9:13, pages 2305-2316.
Read now
Read now
Francesco Turturro. (2007) Denileukin diftitox: a biotherapeutic paradigm shift in the treatment of lymphoid-derived disorders. Expert Review of Anticancer Therapy 7:1, pages 11-17.
Read now
Read now
Eric Jacobsen & Ann LaCasce. (2006) Update on the therapy of highly aggressive non-Hodgkin’s lymphoma. Expert Opinion on Biological Therapy 6:7, pages 699-708.
Read now
Read now
Articles from other publishers (43)
Linxiang Yin & Hatim Thaker. (2023) Cancer Drug Delivery Systems Using Bacterial Toxin Translocation Mechanisms. Bioengineering 10:7, pages 813.
Crossref
Crossref
Samy A. Azer & Aya A. Alsharafi. (2023) Can pharmacy students use Wikipedia as a learning resource? Critical assessment of articles on chemotherapeutic drugs. Advances in Physiology Education 47:2, pages 333-345.
Crossref
Crossref
Sadiya Parveen, Shichun Lun, Michael E Urbanowski, Mitchell Cardin, Jessica Shen, John R Murphy & William R Bishai. (2021) Effective Host-Directed Therapy for Tuberculosis by Depletion of Myeloid-Derived Suppressor Cells and Related Cells Using a Diphtheria Toxin Fusion Protein. The Journal of Infectious Diseases 224:11, pages 1962-1972.
Crossref
Crossref
Alana MacDonald, T.-C. Wu & Chien-Fu Hung. (2021) Interleukin 2-Based Fusion Proteins for the Treatment of Cancer. Journal of Immunology Research 2021, pages 1-11.
Crossref
Crossref
Qiyu Li, Wenjing Li, Keyuan Xu, Yutong Xing, Yu Ding, Zhe Jing, Xi Wang & Zhangyong Hong. (2021) Preclinical evaluation of a novel anti-mesothelin immunotoxin based on a single domain antibody as the targeting ligand. International Journal of Pharmaceutics 602, pages 120647.
Crossref
Crossref
Yutong Xing, Keyuan Xu, Shixiong Li, Li Cao, Yue Nan, Qiyu Li, Wenjing Li & Zhangyong Hong. (2021) A Single-Domain Antibody-Based Anti-PSMA Recombinant Immunotoxin Exhibits Specificity and Efficacy for Prostate Cancer Therapy. International Journal of Molecular Sciences 22:11, pages 5501.
Crossref
Crossref
Ronit Mazor & Ira Pastan. (2020) Immunogenicity of Immunotoxins Containing Pseudomonas Exotoxin A: Causes, Consequences, and Mitigation. Frontiers in Immunology 11.
Crossref
Crossref
Ji-Sun Kim, Sei-Yong Jun & Yong-Sung Kim. (2020) Critical Issues in the Development of Immunotoxins for Anticancer Therapy. Journal of Pharmaceutical Sciences 109:1, pages 104-115.
Crossref
Crossref
Sh. Bayat, M. Zeinoddini, A. Azizi & M. A. Nasiri Khalili. (2019) Co-Solvents Effects on the Stability of Recombinant Immunotoxin Denileukin Diftitox: Structure and Function Assessment. Iranian Journal of Science and Technology, Transactions A: Science 43:5, pages 2091-2097.
Crossref
Crossref
E. Babavalian, M. Zeinoddini, A. R. Saeedinia, R. Mohammadi & N. Xodadadi. (2018) Design of a recombinant immunotoxin against the human granulocyte-colony stimulating factor receptor. Molecular Biology Reports 46:1, pages 1093-1097.
Crossref
Crossref
Irene R. Chassagnon, Sarah J. Piper & Michael J. Landsberg. 2019. Comprehensive Nanoscience and Nanotechnology. Comprehensive Nanoscience and Nanotechnology
279
298
.
Kristin Hirschberger, Anita Jarzebinska, Eva Kessel, Verena Kretzschmann, Manish K. Aneja, Christian Dohmen, Annika Herrmann-Janson, Ernst Wagner, Christian Plank & Carsten Rudolph. (2018) Exploring Cytotoxic mRNAs as a Novel Class of Anti-cancer Biotherapeutics. Molecular Therapy - Methods & Clinical Development 8, pages 141-151.
Crossref
Crossref
Rui Guo, Wenjun Guo, Li Cao, Hui Liu, Jieyu Liu, Hua Xu, Weiqiang Huang, Fengwei Wang & Zhangyong Hong. (2016) Fusion of an albumin-binding domain extends the half-life of immunotoxins. International Journal of Pharmaceutics 511:1, pages 538-549.
Crossref
Crossref
Kelsey J. Weigel, Luqun Shen, Clayton L. Thomas, Daniel Alber, Lauren Drapalik, Zachary T. Schafer & Shaun W. Lee. (2015) Design and evaluation of a peptide‐based immunotoxin for breast cancer therapeutics. FEBS Open Bio 5:1, pages 202-208.
Crossref
Crossref
William N. Hait, Eric Rubin & Joseph R. Bertino. 2015. The Molecular Basis of Cancer. The Molecular Basis of Cancer
635
650.e1
.
Julien Barbier & Daniel Gillet. 2015. The Comprehensive Sourcebook of Bacterial Protein Toxins. The Comprehensive Sourcebook of Bacterial Protein Toxins
1016
1044
.
Satin G. Sawant, Mark R. Fielden & Kurt A. Black. (2014) Evaluation of genotoxicity testing of FDA approved large molecule therapeutics. Regulatory Toxicology and Pharmacology 70:1, pages 87-97.
Crossref
Crossref
Erin L. Boland, Crystal M. Van Dyken, Rachel M. Duckett, Andrew J. McCluskey & Gregory M.K. Poon. (2014) Structural Complementation of the Catalytic Domain of Pseudomonas Exotoxin A. Journal of Molecular Biology 426:3, pages 645-655.
Crossref
Crossref
Dong Hee Na, Eun Ji Park, Myung Sun Kim, Hye Suk Lee & Kang Choon Lee. (2012) Application of Sodium Dodecyl Sulfate-Capillary Gel Electrophoresis to the Characterization of Ricin A-Chain Immunotoxins. Chromatographia 75:11-12, pages 679-683.
Crossref
Crossref
Arutselvan Natarajan. 2012. Antibody‐Mediated Drug Delivery Systems. Antibody‐Mediated Drug Delivery Systems
57
81
.
Yi Wang, Yushui Ma, Ying Fang, Shengdi Wu, Lili Liu, Da Fu & Xizhong Shen. (2012) Regulatory T cell: a protection for tumour cells. Journal of Cellular and Molecular Medicine 16:3, pages 425-436.
Crossref
Crossref
Angelos D. Gritzapis, Ioannis F. Voutsas & Constantin N. Baxevanis. (2011) Ontak reduces the immunosuppressive tumor environment and enhances successful therapeutic vaccination in HER-2/neu-tolerant mice. Cancer Immunology, Immunotherapy 61:3, pages 397-407.
Crossref
Crossref
Swati Choudhary, Mrudula Mathew & Rama S. Verma. (2011) Therapeutic potential of anticancer immunotoxins. Drug Discovery Today 16:11-12, pages 495-503.
Crossref
Crossref
C.-D. Klemke. (2011) Systemische Therapie kutaner LymphomeSystemic treatment of cutaneous lymphomas. Der Hautarzt 62:6, pages 436-443.
Crossref
Crossref
Mark M Aloysius, Alastair J Mc Kechnie, Richard A Robins, Chandan Verma, Jennifer M Eremin, Farzin Farzaneh, Nagy A Habib, Joti Bhalla, Nicola R Hardwick, Sukchai Satthaporn, Thiagarajan Sreenivasan, Mohammed El-Sheemy & Oleg Eremin. (2009) Generation in vivo of peptide-specific cytotoxic T cells and presence of regulatory T cells during vaccination with hTERT (class I and II) peptide-pulsed DCs. Journal of Translational Medicine 7:1.
Crossref
Crossref
H. Miles PrinceSean Whittaker & Richard T. Hoppe. (2009) How I treat mycosis fungoides and Sézary syndrome. Blood 114:20, pages 4337-4353.
Crossref
Crossref
Shai Yarkoni, Yuval Sagiv, Ayelet Kaminitz, Daniel L. Farkas & Nadir Askenasy. (2009) Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins modulates Treg and ameliorates inflammatory colitis. European Journal of Immunology 39:10, pages 2850-2864.
Crossref
Crossref
K. O'Neill, A. Guth, B. Biller, R. Elmslie & S. Dow. (2009) Changes in Regulatory T Cells in Dogs with Cancer and Associations with Tumor Type. Journal of Veterinary Internal Medicine 23:4, pages 875-881.
Crossref
Crossref
Regina Fink-Puches & Lorenzo Cerroni. (2008) Cutaneous T-cell lymphoma and emerging therapies. Drug Discovery Today: Disease Mechanisms 5:1, pages e69-e79.
Crossref
Crossref
William N. Hait, Eric Rubin & Joseph R. Bertino. 2008. The Molecular Basis of Cancer. The Molecular Basis of Cancer
571
581
.
Freddy E EscorciaMichael R McDevittCarlos H VillaDavid A Scheinberg. (2007) Targeted nanomaterials for radiotherapy. Nanomedicine 2:6, pages 805-815.
Crossref
Crossref
Mary T. LitzingerRomaine FernandoTyler J. Curiel, Douglas W. GrosenbachJeffrey SchlomClaudia Palena. (2007) IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity. Blood 110:9, pages 3192-3201.
Crossref
Crossref
J.M.L. White, D. Creamer, A.W.P. du Vivier, A. Pagliuca, A.Y. Ho, S. Devereux, J.R. Salisbury & G.J. Mufti. (2007) Sclerodermatous graft-versus-host disease: clinical spectrum and therapeutic challenges. British Journal of Dermatology 156:5, pages 1032-1038.
Crossref
Crossref
Susanna M. Rybak & Dianne L. Newton. 2007. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies
379
410
.
Ryungsa Kim, Manabu Emi & Kazuaki Tanabe. (2006) Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity. Immunology 119:2, pages 254-264.
Crossref
Crossref
Yingjuan Lu, Jun Yang & Emanuela Sega. (2006) Issues related to targeted delivery of proteins and peptides. The AAPS Journal 8:3, pages E466-E478.
Crossref
Crossref
Jason Gotlib. (2006) KIT Mutations in Mastocytosis and Their Potential as Therapeutic Targets. Immunology and Allergy Clinics of North America 26:3, pages 575-592.
Crossref
Crossref
. (2006) Current Awareness in Hematological Oncology. Hematological Oncology 24:2, pages 89-96.
Crossref
Crossref
Claus-Detlev Klemke, Sergij Goerdt, David Schrama & Jürgen C. Becker. (2006) New insights into the molecular biology and targeted therapy of cutaneous T-cell lymphomas. Journal der Deutschen Dermatologischen Gesellschaft 4:5, pages 395-405.
Crossref
Crossref
P Vaclavkova, Y Cao, L K Wu, J Michalek & E S Vitetta. (2006) A comparison of an anti-CD25 immunotoxin, Ontak and anti-CD25 microbeads for their ability to deplete alloreactive T cells in vitro. Bone Marrow Transplantation 37:6, pages 559-567.
Crossref
Crossref
Thomas A. Luger & Markus Böhm. 2006. The Skin in Systemic Autoimmune Diseases. The Skin in Systemic Autoimmune Diseases
313
324
.
Aurélie Verier, Alexandre Chenal, Aurélie Babon, André Ménez & Daniel Gillet. 2006. The Comprehensive Sourcebook of Bacterial Protein Toxins. The Comprehensive Sourcebook of Bacterial Protein Toxins
991
1007
.
Andrew Zelenetz. 2006. The Lymphomas. The Lymphomas
249
277
.